Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03601676
Other study ID # CN-13-1738-H
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2015
Est. completion date May 30, 2016

Study information

Verified date July 2018
Source Kaiser Permanente
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate the impact of an integrated electronic clinical decision support system to facilitate risk stratification and site-of-care decision-making for patients with acute pulmonary embolism.


Description:

Many low-risk emergency department patients with acute pulmonary embolism are routinely hospitalized despite being eligible for outpatient care. One impediment to home discharge is the difficulty of identifying which patients can safely forego hospitalization. This pragmatic clinical trial intends to evaluate the effect on emergency department disposition of a multicomponent intervention, including electronic clinical decision support system access, physician education, and physician-specific audit and feedback. The hypothesis for this study is that intervention sites, when compared with concurrent control sites, will see an increase in home discharges without an increase in 5-day pulmonary embolism-related return visits or 30-day all-cause mortality.


Recruitment information / eligibility

Status Completed
Enrollment 1703
Est. completion date May 30, 2016
Est. primary completion date April 30, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Acute objectively-confirmed pulmonary embolism, diagnosed in the emergency department

Exclusion Criteria:

- Comfort-care only

- Left the ED against medical advice

- Current PE radiologically diagnosed >12 hrs prior to arrival

- Recent DVT or PE diagnosed within 30 days

- Pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Integration of electronic clinical decision support
Integration of an electronic clinical decision support system into the emergency department patient care workflow to assist with site-of-care decision-making for emergency department patients with acute pulmonary embolism.

Locations

Country Name City State
United States Kaiser Permanente Fremont Emergency Department Fremont California
United States Kaiser Permanente Oakland Emergency Department Oakland California
United States Kaiser Permanente Redwood City Emergency Department Redwood City California
United States Kaiser Permanente Richmond Emergency Department Richmond California
United States Kaiser Permanente Roseville Emergency Department Roseville California
United States Kaiser Permanente Sacramento Emergency Department Sacramento California
United States Kaiser Permanente South Sacramento Emergency Department Sacramento California
United States Kaiser Permanente San Francisco Emergency Department San Francisco California
United States Kaiser Permanente San Jose Emergency Department San Jose California
United States Kaiser Permanente San Leandro Emergency Department San Leandro California
United States Kaiser Permanente San Rafael Emergency Department San Rafael California
United States Kaiser Permanente Santa Clara Emergency Department Santa Clara California
United States Kaiser Permanente Santa Rosa Emergency Department Santa Rosa California
United States Kaiser Permanente South San Francisco Emergency Department South San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
Kaiser Permanente

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of home discharge from the emergency department following treatment for pulmonary embolism 8 months post-implementation compared to 8 months pre-implementation
Secondary Number of participants with major hemorrhage, recurrent venous thromboembolism, and all-cause mortality 30 days
Secondary Number of participants with return visits for pulmonary embolism-related signs, symptoms, or interventions 5 days
See also
  Status Clinical Trial Phase
Recruiting NCT05050617 - Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
Terminated NCT04558125 - Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism Phase 4
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Completed NCT03915925 - Short-term Clinical Deterioration After Acute Pulmonary Embolism
Completed NCT02502396 - Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
Recruiting NCT05171075 - A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE Phase 3
Completed NCT04454554 - Prevalence of Pulmonary Embolism in Patients With Dyspnea on Exertion (PEDIS)
Completed NCT03173066 - Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography Phase 1
Terminated NCT03002467 - Impact Analysis of Prognostic Stratification for Pulmonary Embolism N/A
Completed NCT02611115 - Optimizing Protocols for the Individual Patient in CT Pulmonary Angiography. N/A
Completed NCT02334007 - Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery Phase 1/Phase 2
Completed NCT01975090 - The SENTRY Clinical Study N/A
Not yet recruiting NCT01357941 - Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE) N/A
Completed NCT01326507 - Prognostic Value of Heart-type Fatty Acid-Binding Protein (h-FABP) in Acute Pulmonary Embolism N/A
Completed NCT00771303 - Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
Completed NCT02476526 - Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease Phase 4
Completed NCT00780767 - Angiojet Rheolytic Thrombectomy in Case of Massive Pulmonary Embolism Phase 2
Completed NCT00773448 - Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism N/A
Completed NCT00720915 - D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months N/A
Completed NCT00244725 - Odiparcil For The Prevention Of Venous Thromboembolism Phase 2